Voglibose

Drug Profile

Voglibose

Alternative Names: A 71100; AO-128; Basen; Glustat; Voglistat

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Takeda
  • Class Antihyperglycaemics; Inositol phosphates; Small molecules; Sugar alcohols
  • Mechanism of Action Alpha-glucosidase inhibitors; Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Type 2 diabetes mellitus

Most Recent Events

  • 29 Apr 2016 Biomarkers information updated
  • 29 Apr 2013 Launched for Type-2 diabetes mellitus in Thailand (PO) prior to April 2013
  • 03 Nov 2011 Launched for Type-2 diabetes mellitus in Philippines (PO) prior to November 2011
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top